Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

Smoking May Spark Reaction Tied to Dementia
NewsApr 28, 2026

Smoking May Spark Reaction Tied to Dementia

A University of Chicago team discovered that nicotine triggers a previously unknown lung‑brain signaling pathway. Pulmonary neuroendocrine cells (PNECs) release exosomes packed with serotransferrin, which upset iron regulation in neurons and spark oxidative damage linked to dementia. The researchers created...

By Futurity
A Popular Senolytic Treatment Causes Brain Damage in Mice
BlogApr 28, 2026

A Popular Senolytic Treatment Causes Brain Damage in Mice

A recent PNAS study shows that the widely used senolytic cocktail dasatinib plus quercetin (D+Q) impairs myelination in the mouse corpus callosum. The treatment altered oligodendrocyte morphology within minutes, reduced myelin thickness, and triggered endoplasmic reticulum stress, without killing the...

By SENS (Lifespan Research Institute) News
Discovery May Upend Ideas About the Cause of Hydrocephalus
NewsApr 28, 2026

Discovery May Upend Ideas About the Cause of Hydrocephalus

New research led by Stony Brook neurosurgeon Michael Egnor challenges the century‑old belief that hydrocephalus results from impaired cerebrospinal fluid absorption. The team proposes that failure to absorb pulsatile energy from the heartbeat—described as a malfunction of the cerebral windkessel...

By Futurity
Apple Vision Pro Enables First Spatial-Computing Cataract Surgery
SocialApr 28, 2026

Apple Vision Pro Enables First Spatial-Computing Cataract Surgery

An ophthalmologist in San Diego just performed the first Apple Vision Pro-assisted cataract eye surgery. Dr. Tommy Korn (aka medicine's first "chief spatial computing medical officer") did it as part of a clinical study. Main benefits are easy access to patient info (visual...

By Trung Phan
Multiple Myeloma Sequencing Evolves With CAR T, MRD Insights: Sylvester Homsy, MD
NewsApr 28, 2026

Multiple Myeloma Sequencing Evolves With CAR T, MRD Insights: Sylvester Homsy, MD

At an Institute for Value‑Based Medicine event in Charlotte, Sylvester Homsy, MD highlighted how CAR‑T cell therapy and bispecific antibodies are reshaping multiple myeloma treatment sequencing. The emergence of B‑cell maturation antigen‑targeted agents is prompting clinicians to consider these high‑efficacy...

By AJMC (The American Journal of Managed Care)
CDR vs ACDF in the Back to Work Sweepstakes. Who Wins?
BlogApr 28, 2026

CDR vs ACDF in the Back to Work Sweepstakes. Who Wins?

A new meta‑analysis of 16 randomized trials involving more than 5,600 patients compares anterior cervical discectomy and fusion (ACDF) with cervical disc replacement (CDR). The data show CDR patients return to work significantly faster – 33% more likely at six...

By OTW Spine Research Hub
Why Microbot Medical Developed a Fully Disposable Surgical Robot
NewsApr 28, 2026

Why Microbot Medical Developed a Fully Disposable Surgical Robot

Microbot Medical received FDA 510(k) clearance in September 2025 for its fully disposable Liberty surgical robot, designed for peripheral endovascular navigation. The single‑use system combines a compact drive unit, remote controller, and mounting arm that can be set up in...

By Medical Design & Outsourcing
Study Finds Season of Entry Impacts Childhood Obesity Outcomes
NewsApr 28, 2026

Study Finds Season of Entry Impacts Childhood Obesity Outcomes

A secondary analysis of New Zealand’s Whānau Pakari program examined 397 children aged 3.7‑16.8 years to determine whether the season of enrollment influences six‑month BMI outcomes. Overall, 68% reduced their BMI‑SD score by an average of 0.16, but spring entrants showed no significant...

By News-Medical.Net
US Pricing Reform Reshapes Drug Launch Strategies: Dee Chaudhary
NewsApr 28, 2026

US Pricing Reform Reshapes Drug Launch Strategies: Dee Chaudhary

U.S. drug‑pricing reforms, especially the Most Favored Nation (MFN) rule, are forcing manufacturers to align American prices with the lowest prices offered abroad. As a result, firms are pulling back from launches in France, Germany and the Nordic region to...

By AJMC (The American Journal of Managed Care)
Scientists Uncover a Hidden Mechanism Cancer Cells Use to Rewrite Genetic Messages, Revealing a Promising New Target for Treatment
NewsApr 28, 2026

Scientists Uncover a Hidden Mechanism Cancer Cells Use to Rewrite Genetic Messages, Revealing a Promising New Target for Treatment

A team of molecular biologists has uncovered a previously unknown RNA‑binding protein that rewrites messenger‑RNA messages in cancer cells, effectively reprogramming gene expression. The discovery explains how tumors can rapidly adapt to hostile environments and develop resistance to standard chemotherapy....

By Bioengineer.org
How Age, Sex, and Cancer Type Shape the Risk of New Cancers in Survivors
NewsApr 28, 2026

How Age, Sex, and Cancer Type Shape the Risk of New Cancers in Survivors

A new epidemiological study of more than 1.2 million cancer survivors reveals that age, sex, and the original cancer type dramatically influence the likelihood of developing a second primary malignancy. Survivors over 65 face up to a 60% higher risk,...

By Bioengineer.org
Pasadena Clinic Received $34 Million in Medicare Skin Graft Scam, Court Documents Say
NewsApr 28, 2026

Pasadena Clinic Received $34 Million in Medicare Skin Graft Scam, Court Documents Say

Federal prosecutors seized over $2 million from Expert Wound Care, a Pasadena clinic accused of billing Medicare $34 million for skin‑graft procedures that patients never received. The scheme involved 78 beneficiaries, with a single patient billed more than $6 million. Medicare’s spending on...

By Los Angeles Times – Movies
Medicare Won’t Cover It: 5 Common Health Expenses That May Blindside Retirees
NewsApr 28, 2026

Medicare Won’t Cover It: 5 Common Health Expenses That May Blindside Retirees

Medicare leaves significant gaps that can surprise retirees, especially for routine dental, vision and hearing services that are largely excluded from Original Medicare. The most costly omission is long‑term care, with a 65‑year‑old needing roughly $135,000 to cover future expenses,...

By Money.com
Hospitals Prioritize Profit Over People in Health Policy
SocialApr 28, 2026

Hospitals Prioritize Profit Over People in Health Policy

Quick reminder that hospitals are not on the side of the people when it comes to health policy

By Rhet Lage (public health advocate)
With Cell and Gene Therapies Proliferation, Specialty Pharmacy Faces New Pricing, Distribution Pressures
BlogApr 28, 2026

With Cell and Gene Therapies Proliferation, Specialty Pharmacy Faces New Pricing, Distribution Pressures

Cell and gene therapies are moving from ultra‑rare indications to broader patient populations, prompting a fundamental redesign of specialty‑pharmacy distribution and pricing models. At the 2026 Asembia meeting, experts warned that current flash‑title and buy‑and‑bill channels may not scale to...

By Pharmaceutical Commerce (independent trade)
New Clinical Guidelines Significantly Reduce Opioid Prescriptions After Ear Surgery
NewsApr 28, 2026

New Clinical Guidelines Significantly Reduce Opioid Prescriptions After Ear Surgery

A retrospective analysis of more than 25,000 patients across 80 U.S. health systems shows that the American Academy of Otolaryngology‑Head and Neck Surgery Foundation’s opioid prescribing guideline, released in April 2021, immediately reduced postoperative opioid prescriptions after parotidectomy. Data from the...

By News-Medical.Net
Pharmaceutical Executive Daily: FDA Approves Breztri
BlogApr 28, 2026

Pharmaceutical Executive Daily: FDA Approves Breztri

Sun Pharmaceutical Industries agreed to buy Organon for $11.75 billion, propelling the combined entity into the top‑25 global pharma ranks. IMG Pharmaceutical announced the acquisition of Japan’s Matsumoto Pharmaceutical, adding a portfolio with more than 50 OTC approvals. The FDA granted...

By Pharmaceutical Executive (independent trade outlet)
VCU Study Identifies Key Factors Driving Risk of Second Cancers
NewsApr 28, 2026

VCU Study Identifies Key Factors Driving Risk of Second Cancers

Researchers at Virginia Commonwealth University examined data from more than 3 million U.S. cancer survivors spanning 1975‑2019, revealing that the likelihood of a second primary cancer depends heavily on age at initial diagnosis, sex, and the type of first cancer. Older...

By News-Medical.Net
How Price Transparency Could Fix the Abandoned Rx Issue: Laura Jensen
NewsApr 28, 2026

How Price Transparency Could Fix the Abandoned Rx Issue: Laura Jensen

GoodRx’s chief commercial officer Laura Jensen argued that greater drug‑price transparency could dramatically cut the roughly one billion annual abandoned prescriptions in the United States. Speaking at Asembia’s AXS26 conference, she highlighted how transparent, consumer‑facing platforms can deliver easier‑to‑access discounts for...

By AJMC (The American Journal of Managed Care)
Endurance Exercise Protects Joints, Boosts Fat Oxidation
SocialApr 28, 2026

Endurance Exercise Protects Joints, Boosts Fat Oxidation

Ha... no. He's wrong. Yes, there's an Afib signal. But his other conclusions... no. Run and cycle... we know why we do it... and my patients who run/ride are by far better off than those who don't. You need...

By Howard Luks, MD
Proposing Medicare Over Medicaid for Home-Based Long-Term Care
SocialApr 28, 2026

Proposing Medicare Over Medicaid for Home-Based Long-Term Care

My look at a plan to shift home and community based long-term care from Medicaid to Medicare https://t.co/kIHQ5jBHJ3 #medicare #medicaid #seniors #hcbs #longtermcare #peoplewithdisabilities

By Howard Gleckman
New AI Models Quickly Find Compounds that Target Lyme Bacteria
NewsApr 28, 2026

New AI Models Quickly Find Compounds that Target Lyme Bacteria

Tufts University researchers have leveraged AI and machine‑learning to rapidly pinpoint narrow‑spectrum antibiotics that kill the Lyme disease bacterium Borrelia burgdorferi. Screening 60,000 existing compounds yielded several hundred hits, and generative models now explore an estimated 10^60 drug‑like molecules to...

By News-Medical.Net
FDA Partners with AZN, AMGN to Accelerate AI-Driven Trials
SocialApr 28, 2026

FDA Partners with AZN, AMGN to Accelerate AI-Driven Trials

FDA launches effort with $AZN $AMGN to speed up clinical trials, using AI https://t.co/k4LjxnDLmq via @LizzyLaw_

By Adam Feuerstein
Supreme Court Case Could Broaden Vascepa Generic Labeling
SocialApr 28, 2026

Supreme Court Case Could Broaden Vascepa Generic Labeling

Vascepa "skinny label" generic case at the Supreme Court. The generic label is only for hypertriglyceridemia, while Vascepa label is much broader. But gets promoted as a generic for Vascepa. Impact might be substantial. https://t.co/xtGWtscXkc

By Peter Suzman
Implant Trade Secrets Are Not Protectable Due to Disclosure in Patents
NewsApr 28, 2026

Implant Trade Secrets Are Not Protectable Due to Disclosure in Patents

The Federal Circuit ruled that trade secrets disclosed in patents are unprotectable under the California Uniform Trade Secrets Act, reversing a district court decision in International Medical Devices, Inc. v. Cornell. The court found three of IMD’s alleged secrets “generally...

By JD Supra – Legal Tech
Medevac Helicopters Use Roadside LZs for Familiarization Flights
SocialApr 28, 2026

Medevac Helicopters Use Roadside LZs for Familiarization Flights

There are a lot of reasons a helo, esp a medevac, would land next to a road. One common reason is that medical helicopters will conduct familiarization flights and land at pre-approved LZs (some of which are private) in their...

By Nathan Strang
Breaking: Fauci’s Top Advisor Charged in COVID Cover-Up Case
BlogApr 28, 2026

Breaking: Fauci’s Top Advisor Charged in COVID Cover-Up Case

David Morens, a longtime senior advisor to Dr. Anthony Fauci, was indicted by the Department of Justice on charges of conspiracy and destruction of federal records. Prosecutors allege he used private email accounts to move COVID‑related discussions off official systems,...

By Dr. Gator - Between a Shot and Hard Place
Advanced Gene Editing ‘Promising’ for Sickle Cell Disease
NewsApr 28, 2026

Advanced Gene Editing ‘Promising’ for Sickle Cell Disease

Two recent New England Journal of Medicine studies demonstrate that CRISPR‑Cas12a (reni‑cel) and base‑editing (risto‑cel) autologous stem‑cell therapies can dramatically raise fetal hemoglobin and normalize total hemoglobin in sickle cell patients. The RUBY trial reported a rise from 2.5% to...

By Healio
Human-Centered Digital Transformation in Specialty Pharmacy
NewsApr 28, 2026

Human-Centered Digital Transformation in Specialty Pharmacy

At the AXS26 Summit, AcariaHealth executives outlined a human‑centered digital transformation for specialty pharmacy that streamlines workflows while keeping personal clinician contact. They showcased a secure‑messaging onboarding process that trims a typical 45‑minute intake call to a brief exchange and...

By AJMC (The American Journal of Managed Care)
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
BlogApr 28, 2026

Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs

At the Asembia AXS26 Summit, Clarivate’s Dee Chaudhary warned that U.S. drug‑pricing policy is moving from theory to real‑time execution, reshaping payer behavior and market volatility. The Inflation Reduction Act’s Medicare price negotiations, the new One Big, Beautiful Bill Act, and renewed Most Favored...

By Pharmaceutical Executive (independent trade outlet)
FDA Debuts Plan to Collect Real-Time Clinical Trial Data
NewsApr 28, 2026

FDA Debuts Plan to Collect Real-Time Clinical Trial Data

The U.S. Food and Drug Administration announced a pilot program that will collect clinical‑trial data in real time, allowing scientific reviewers to see information as it is generated. The initiative, launched on Tuesday, includes participation from major drugmakers AstraZeneca and...

By Endpoints News
How to Implement AI-Powered Coronary Plaque Analysis Software—And Ensure You Get Paid
NewsApr 28, 2026

How to Implement AI-Powered Coronary Plaque Analysis Software—And Ensure You Get Paid

Artificial intelligence is now being used to analyze coronary plaque in CT angiography, offering detailed, non‑invasive assessments of coronary artery disease. Medicare expanded coverage and introduced Category 1 CPT codes in 2024, allowing providers to be reimbursed for AI‑driven plaque analysis....

By Cardiovascular Business
Aylward Enterprises Highlights Custom Packaging Automation Solutions for Complex Solid-Dose Applications
NewsApr 28, 2026

Aylward Enterprises Highlights Custom Packaging Automation Solutions for Complex Solid-Dose Applications

Aylward Enterprises showcased its Custom Packaging Automation portfolio, targeting complex oral solid‑dose (OSD) products such as quick‑dissolve capsules, softgels, and irregularly shaped tablets. Leveraging proprietary feeding, filling and robotic technologies, the company delivers integrated lines that move blisters to cartoners,...

By Manufacturing Tomorrow
Federated Machine Learning Gives Healthcare Organizations a Competitive AI Advantage
NewsApr 28, 2026

Federated Machine Learning Gives Healthcare Organizations a Competitive AI Advantage

Federated machine learning lets health systems train AI models on‑site, sending only model updates to a central server. This decentralized approach preserves patient privacy while aggregating insights from multiple hospitals, such as Mayo Clinic and Vanderbilt University, using NVIDIA‑powered platforms....

By HealthTech Magazine
GLP-1 Receptor Agonist Add-On at Immune Checkpoint Inhibitor Initiation and Fewer Wasting-Related Diagnoses and Acute-Care Episodes in People with Cancer...
NewsApr 28, 2026

GLP-1 Receptor Agonist Add-On at Immune Checkpoint Inhibitor Initiation and Fewer Wasting-Related Diagnoses and Acute-Care Episodes in People with Cancer...

A target‑trial emulation of US TriNetX data examined cancer patients with obesity who started immune checkpoint inhibitors (ICIs) and received a GLP‑1 receptor agonist (GLP‑1 RA) at initiation. After 1:1 propensity matching, 988 patients per arm were followed for up to...

By Research Square – News/Updates
Cutting Cancer Care Costs, Rethinking ACA Policy: Justin Favaro, MD
NewsApr 28, 2026

Cutting Cancer Care Costs, Rethinking ACA Policy: Justin Favaro, MD

At the Institute for Value‑Based Medicine conference in Charlotte, oncologist Justin Favaro highlighted how independent oncology practices can dramatically lower chemotherapy costs and deliver care at roughly $1,000 per Medicare patient in annual savings. He noted that health‑care now accounts...

By AJMC (The American Journal of Managed Care)
Trump Admin Revives COVID Origins Debate with Indictment
NewsApr 28, 2026

Trump Admin Revives COVID Origins Debate with Indictment

The Justice Department has indicted David Morens, a former senior adviser at the National Institute of Allergy and Infectious Diseases, on conspiracy and record‑tampering charges for allegedly deleting emails and routing communications to a personal account to hide information about...

By Axios – General
Reproductive Health Service Utilization and Associated Factors Among Womens With Disabilities in Gedeo Zone, Southern Ethiopia: Cross-Sectional Study
NewsApr 28, 2026

Reproductive Health Service Utilization and Associated Factors Among Womens With Disabilities in Gedeo Zone, Southern Ethiopia: Cross-Sectional Study

A cross‑sectional study of 605 women with disabilities in Ethiopia’s Gedeo Zone found that only 15.7% accessed sexual and reproductive health (SRH) services in the past year. The majority were single, rural, and physically impaired, with 94.5% not using family‑planning...

By Research Square – News/Updates
Two Tiers Too Many. Re: Doctors’ Distinct Work and Professional Role Can’t Be Parcelled Into Generic Tasks for “Tiers” Of...
NewsApr 28, 2026

Two Tiers Too Many. Re: Doctors’ Distinct Work and Professional Role Can’t Be Parcelled Into Generic Tasks for “Tiers” Of...

A BMJ letter from retired consultant psychiatrist David Bowker argues that the NHS’s push toward generic “tiers” of healthcare staff erodes the distinct professional role of doctors. He cites the experience of psychiatrists trained in the 1970s who later faced...

By BMJ (Latest)
Pfizer Secures Patent Extension for Leading Rare‑Disease Drug
SocialApr 28, 2026

Pfizer Secures Patent Extension for Leading Rare‑Disease Drug

Pfizer deals extend patent life for a top-selling rare disease drug https://t.co/uXXbtLaIOL $PFE $BBIO $ALNY $IONS

By Ben Fidler
Pfizer Delays Patent Cliff for Blockbuster Vyndamax
NewsApr 28, 2026

Pfizer Delays Patent Cliff for Blockbuster Vyndamax

Pfizer announced a two‑year extension of market exclusivity for Vyndamax (tafamidis), pushing the expected generic launch to 2026. The extension stems from a new formulation patent and a pediatric study that grant additional protection. Vyndamax, approved for transthyretin amyloid cardiomyopathy,...

By Endpoints News
Dual-Agonist Survodutide Shows Significant Weight Loss in Phase III Obesity Trial
NewsApr 28, 2026

Dual-Agonist Survodutide Shows Significant Weight Loss in Phase III Obesity Trial

Boehringer Ingelheim reported that its dual glucagon/GLP‑1 agonist survodutide produced up to 16.6% average weight loss after 76 weeks in the Phase III SYNCHRONIZE‑1 trial. The study also showed that 85.1% of treated participants achieved at least a 5% reduction, with...

By BioPharm International
What’s the Actual Neurological Cost of a 3-Column Osteotomy?
BlogApr 28, 2026

What’s the Actual Neurological Cost of a 3-Column Osteotomy?

A prospective multicenter study of 553 adult spinal deformity patients found that 130 (23.5%) underwent a three‑column osteotomy (3CO). Neurologic adverse events occurred in 23.1% of 3CO cases versus 15.4% without a 3CO, a statistically significant increase. Despite the higher...

By OTW Spine Research Hub
Tiny Chip Delivers High‑Bandwidth Wireless Brain Interface
SocialApr 28, 2026

Tiny Chip Delivers High‑Bandwidth Wireless Brain Interface

Ultra-Compact Brain–Computer Interface Chip Enables High-Bandwidth Wireless Neural Communication by @CUSEAS #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/gaulMV302i

By Ron van Loon
Uveitis Attack History May Predict Cataract Surgery Outcomes
NewsApr 28, 2026

Uveitis Attack History May Predict Cataract Surgery Outcomes

Researchers at Turkey's Uak Training and Research Hospital examined 54 eyes with uveitis‑associated cataracts that underwent phacoemulsification and intra‑ocular lens implantation. Each additional uveitis attack added roughly 1.29 days to postoperative topical steroid therapy and was modestly linked to poorer...

By Healio
Psychedelics May Reverse Epigenetic Roots of Addiction
SocialApr 28, 2026

Psychedelics May Reverse Epigenetic Roots of Addiction

Epigenetic Mechanisms of Psychedelics in Addiction: Emerging Evidence and Therapeutic Potential these compounds may directly counteract the epigenetic and transcriptional imprints that sustain compulsive substance use https://t.co/GJyHoLPL83

By Julie Holland
Hikma and Amarin's Generic Drug Case Heads to Supreme Court Arguments
NewsApr 28, 2026

Hikma and Amarin's Generic Drug Case Heads to Supreme Court Arguments

The U.S. Supreme Court will hear arguments this week in the dispute between Hikma Pharmaceuticals and Amarin over a prescription‑strength fish‑oil pill, the first generic challenge to Amarin’s Vascepa. The case centers on whether the FDA’s bioequivalence standards and the...

By Endpoints News
BIOTECanada Responds to Health Canada’s Gazette on a Draft Order Providing for Reliance on International Regulatory Authorities
NewsApr 28, 2026

BIOTECanada Responds to Health Canada’s Gazette on a Draft Order Providing for Reliance on International Regulatory Authorities

Health Canada’s Gazette released a draft Order that would allow Canadian regulators to rely on approvals from trusted foreign agencies, a key component of the Red Tape Review initiative. BIOTECanada praised the proposal, calling it a meaningful step toward faster...

By BIOTECanada
PCI Benefits Stable Patients More in Focal vs Diffuse Disease: ORBITA-2
NewsApr 28, 2026

PCI Benefits Stable Patients More in Focal vs Diffuse Disease: ORBITA-2

A new ORBITA‑2 sub‑analysis shows that patients with focal coronary disease experience markedly greater angina relief from PCI than those with diffuse disease. Using pressure‑wire iFR pullbacks, investigators found an odds ratio of 1.80 for symptom improvement and 1.55 for...

By TCTMD